Design of PI3K-mTOR Dual Inhibitors for Ovarian Cancer: Are We on the Right Track?

Autor: Mangala SK; Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education [MAHE], Manipal, Karnataka 576104, India., Rathi E; Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education [MAHE], Manipal, Karnataka 576104, India., Udupa KS; Department of Medical Oncology, Kasturba Medical College, Manipal Academy of Higher Education [MAHE], Manipal, Karnataka 576104, India., Shama PK; Department of Cell and Molecular Biology, Manipal School of Life Sciences, Manipal Academy of Higher Education [MAHE], Manipal, Karnataka 576104, India., Pai KSR; Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education [MAHE], Manipal, Karnataka 576104, India., Kini SG; Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education [MAHE], Manipal, Karnataka 576104, India.

Publikováno v: Current medicinal chemistry [Curr Med Chem] 2024 Apr 04. Date of Electronic Publication: 2024 Apr 04.